adult height was an indicator of how a society fosters its youths. Tanner did early research on the use of human growth hormone to address children whose growth was significantly delayed and was responsible for selecting the small handful of children in the UK who would be treated with the limited supply of HGH extracted from human cadavers. After a number of patients worldwide died in 1985 of Creutzfeldt–Jakob disease linked to HGH treatments, Tanner immediately stopped the therapy, but had patients who insisted that they were willing to take the risk to address their child's delayed growth. Treatments resumed in the 1990s following the introduction of genetically engineered human growth hormone. Tanner died at age 90 on 11 August 2010 in Wellington, Somerset, due to a stroke and prostate cancer. He was survived by his second wife, Gunilla, as well as by a daughter, Helen Phillips, a stepdaughter, a stepson and three granddaughters. Publications Tanner authored and co-authored numerous publications and contributions to publications, some of which are listed below. Growth at Adolescence, 2nd ed. (1962) Oxford: Blackwell Scientific. Transferred to digital printing 2002. Transferred to digital printing 2003. References 1920 births 2010 deaths Alumni of the University of Exeter Academics of the University of London British paediatric endocrinologists People from Camberley Perelman School of Medicine at the University of Pennsylvania alumni People educated at Marlborough College Auxologists Recipients of the James Spence Medal British expatriates in the United States